Published in Eur Heart J on August 26, 2011
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J (2014) 1.55
Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease. J Am Heart Assoc (2014) 1.50
Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans. J Physiol (2013) 1.39
The Diagnosis and Treatment of Peripheral Arterial Vascular Disease. Dtsch Arztebl Int (2016) 1.33
The diagnosis, treatment and follow-up of extracranial carotid stenosis. Dtsch Arztebl Int (2013) 1.22
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation (2014) 1.18
The hyperaemic response to passive leg movement is dependent on nitric oxide: a new tool to evaluate endothelial nitric oxide function. J Physiol (2012) 1.03
In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure. Stem Cell Reports (2015) 0.97
Automated photoplethysmography-based determination of ankle-brachial index: a validation study against Doppler sonography. Clin Res Cardiol (2012) 0.96
Current utility of the ankle-brachial index (ABI) in general practice: implications for its use in cardiovascular disease screening. BMC Fam Pract (2014) 0.94
Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging. BMC Cardiovasc Disord (2012) 0.90
Peripheral arterial disease of the lower extremities. Arch Med Sci (2012) 0.89
Korean Guidelines for Interventional Recanalization of Lower Extremity Arteries. Korean J Radiol (2015) 0.88
Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis. Mediators Inflamm (2015) 0.86
Renal artery stenosis predicts coronary artery disease in patients with hypertension. PLoS One (2013) 0.86
Pulse pressure and subclinical peripheral artery disease. J Hum Hypertens (2013) 0.85
Therapeutic angiogenesis in critical limb ischemia. Angiology (2012) 0.85
Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol (2015) 0.85
Relation between the ankle-brachial index and the complexity of coronary artery disease in older patients. Clin Interv Aging (2013) 0.84
New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition. PLoS One (2014) 0.84
Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. J Cardiovasc Magn Reson (2016) 0.83
Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions. Circ Cardiovasc Imaging (2012) 0.83
Diabetes and vascular disease in different arterial territories. Diabetes Care (2014) 0.83
The role of atherectomy in the treatment of lower extremity peripheral artery disease. BMC Surg (2012) 0.83
Peripheral arterial disease and chronic heart failure: a dangerous mix. Heart Fail Rev (2013) 0.83
Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease. J Am Heart Assoc (2016) 0.82
Diagnostic Accuracy Study of an Oscillometric Ankle-Brachial Index in Peripheral Arterial Disease: The Influence of Oscillometric Errors and Calcified Legs. PLoS One (2016) 0.82
Let's talk about sex : (title of a song from 1991 by 'Salt 'n Pepa'). Neth Heart J (2013) 0.82
Optimal Scanning Protocols for Dual-Energy CT Angiography in Peripheral Arterial Stents: An in Vitro Phantom Study. Int J Mol Sci (2015) 0.82
Use of statins in lower extremity artery disease: a review. BMC Surg (2012) 0.81
Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication. BMC Surg (2012) 0.81
Safety and efficacy assessment of carotid artery stenting in a high-risk population in a single-centre registry. Postepy Kardiol Interwencyjnej (2014) 0.81
Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis. J Clin Neurol (2013) 0.81
Twelve-months follow-up of supervised exercise after percutaneous transluminal angioplasty for intermittent claudication: a randomised clinical trial. Int J Environ Res Public Health (2013) 0.81
Transradial approach for the endovascular treatment of type I endoleak after aortic aneurysm repair: a case report. BMC Surg (2013) 0.81
Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania. Clin Interv Aging (2015) 0.81
Challenges associated with peripheral arterial disease in women. Vasc Health Risk Manag (2014) 0.81
New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human. PLoS One (2014) 0.81
The role of ankle-brachial index for predicting peripheral arterial disease. Maedica (Buchar) (2014) 0.81
Estimation of pulse wave velocity in patients with peripheral artery disease: a word of caution. Hypertens Res (2015) 0.80
New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases. PLoS One (2014) 0.80
Genome-Wide Association Study of Peripheral Arterial Disease in a Japanese Population. PLoS One (2015) 0.80
Recent update of guidelines for neurointerventional procedures. Neurointervention (2013) 0.80
Local association between endothelial dysfunction and intimal hyperplasia: relevance in peripheral artery disease. J Am Heart Assoc (2015) 0.80
Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence. Vasc Health Risk Manag (2015) 0.79
Screen or not to screen for peripheral arterial disease: guidance from a decision model. BMC Public Health (2014) 0.79
Automated plethysmographic measurement of the ankle-brachial index: a comparison with the doppler ultrasound method. Hypertens Res (2015) 0.79
Mean platelet volume levels in the presence of angiographically documented peripheral artery disease. Int J Clin Exp Med (2015) 0.79
Treating femoropopliteal disease: established and emerging technologies. Semin Intervent Radiol (2014) 0.79
Prevalence of arterial stiffness and the risk of myocardial diastolic dysfunction in women. Biosci Rep (2016) 0.78
Femoropopliteal Artery Stent Fracture with Recurrent In-Stent Reocclusion and Aneurysm Formation: Successful Treatment with Self-Expandable Viabahn Endoprosthesis. Korean Circ J (2015) 0.78
Popliteal artery thrombosis following total knee arthroplasty managed successfully with percutaneous intervention. BMJ Case Rep (2014) 0.78
Clinical and morphological features of patients who underwent endovascular interventions for lower extremity arterial occlusive diseases. Postepy Kardiol Interwencyjnej (2015) 0.78
Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J (2015) 0.78
Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study. Clin Res Cardiol (2015) 0.78
Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study. Cardiovasc Diabetol (2014) 0.78
Predictors of minor versus major stroke during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Clin Res Cardiol (2014) 0.78
Management of Critical Limb Ischemia. Circ Cardiovasc Interv (2016) 0.77
Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects. Redox Biol (2017) 0.77
Carotid intima media thickness and blood biomarkers of atherosclerosis in patients after stroke or myocardial infarction. Croat Med J (2016) 0.77
Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease. Wien Klin Wochenschr (2014) 0.77
High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea. Clin Res Cardiol (2015) 0.77
Association of Dialysis Duration with Outcomes after Transplantation in a Japanese Cohort. Clin J Am Soc Nephrol (2016) 0.77
Pickering syndrome: high-risk stenting of a renal artery stenosis in a multimorbid patient presenting with progressive congestive heart failure. Clin Res Cardiol (2013) 0.76
Understanding and treating hypertension in diabetic populations. Cardiovasc Diagn Ther (2015) 0.76
Off-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study. Int J Cardiovasc Imaging (2016) 0.76
Influence of exercise training on proangiogenic TIE-2 monocytes and circulating angiogenic cells in patients with peripheral arterial disease. Clin Res Cardiol (2016) 0.76
Potential of thermal imaging as a tool for prediction of cardiovascular disease. J Med Phys (2014) 0.76
Peripheral arterial disease in the Middle East: Underestimated predictor of worse outcome. Glob Cardiol Sci Pract (2013) 0.75
Impaired Femoral Vascular Compliance and Endothelial Dysfunction in 30 Healthy Male Soccer Players: Competitive Sports and Local Detrimental Effects. Sports Health (2015) 0.75
Validation of pressure gradient and peripheral fractional flow reserve measured by a pressure wire for diagnosis of iliofemoral artery disease with intermediate stenosis. Med Devices (Auckl) (2015) 0.75
C-reactive protein, renal function, and cardiovascular outcome in patients with symptomatic peripheral artery disease and preserved left ventricular systolic function. Croat Med J (2015) 0.75
Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link? World J Diabetes (2014) 0.75
Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials. Open Heart (2014) 0.75
Risk Factors for Carotid Artery Stenosis in Chinese Patients Undergoing Coronary Artery Bypass Graft Interventions. Medicine (Baltimore) (2015) 0.75
Effectiveness of a new exercise program after lower limb arterial blood flow surgery in patients with peripheral arterial disease: a randomized clinical trial. Int J Environ Res Public Health (2014) 0.75
A New 2D-Based Method for Carotid Intima-Media Thickness Quantification From Ultrasound Sequences. Iran Red Crescent Med J (2015) 0.75
Evidence for management of carotid artery stenosis. Neurol Med Chir (Tokyo) (2015) 0.75
Evidence-Based Carotid Interventions for Stroke Prevention: State-of-the-art Review. J Atheroscler Thromb (2017) 0.75
Evaluation of the 4-French Pulsar-18 Self-expanding Nitinol Stent in Long Femoropopliteal Lesions. Clin Med Insights Cardiol (2015) 0.75
Clinical Analysis Comparing Efficacy between a Distal Filter Protection Device and Proximal Balloon Occlusion Device during Carotid Artery Stenting. J Korean Neurosurg Soc (2015) 0.75
Clopidogrel for Atherothrombotic Event Management in Patients with Peripheral Arterial Disease (COOPER) Study: Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients. Ann Vasc Dis (2012) 0.75
Lower extremity amputation in peripheral artery disease: improving patient outcomes. Vasc Health Risk Manag (2014) 0.75
Transpopliteal balloon-assisted excimer-laser atherectomy for the treatment of chronic femoropopliteal occlusions: feasibility and initial results. Clin Med Insights Cardiol (2015) 0.75
Is Extended Duration of Dual Antiplatelet Therapy After Carotid Stenting Beneficial? Medicine (Baltimore) (2015) 0.75
Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health Qual Life Outcomes (2015) 0.75
Fibromuscular dysplasia--a rare cause of renovascular hypertension. Case study and overview of the literature data. J Med Life (2012) 0.75
Increased leg blood flow and improved femoral artery shear patterns in metabolic syndrome after a diet and exercise programme. Clin Physiol Funct Imaging (2013) 0.75
Pharmacology in peripheral arterial disease: what the interventional radiologist needs to know. Semin Intervent Radiol (2014) 0.75
Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment. Ont Health Technol Assess Ser (2015) 0.75
New cerebral lesions at magnetic resonance imaging after carotid artery stenting versus endarterectomy: an updated meta-analysis. PLoS One (2015) 0.75
The Importance of Patency in Patients with Critical Limb Ischemia Undergoing Endovascular Revascularization for Infrapopliteal Arterial Disease. Front Cardiovasc Med (2015) 0.75
Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania. Clin Interv Aging (2015) 0.75
Compromised visceral circulation does not affect the outcome of colorectal surgery. Surg Today (2013) 0.75
Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients. Diagn Interv Radiol (2014) 0.75
Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease. Drugs (2014) 0.75
Health Effects of the Programmed Physical Activities on Lipid Profile in Peripheral Arterial Disease of the Lower Extremities. Med Arch (2015) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86
Universal definition of myocardial infarction. Circulation (2007) 11.69
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA (2006) 9.27
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J (2004) 7.84
The risk of recurrent venous thromboembolism in men and women. N Engl J Med (2004) 7.41
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet (2013) 7.03
Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med (2006) 6.51
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA (2010) 6.29
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47
Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol (2011) 5.46
Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol (2004) 5.44
Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med (2014) 5.41
Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med (2009) 5.26
Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med (2014) 5.25
Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol (2013) 5.11
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 5.03
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA (2006) 5.00
Use of ramipril in preventing stroke: double blind randomised trial. BMJ (2002) 4.91
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med (2013) 4.67
Lyme borreliosis. Lancet Infect Dis (2003) 4.58
Resting heart rate in cardiovascular disease. J Am Coll Cardiol (2007) 4.14
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet (2009) 4.10
The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J (2006) 4.10
Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation (2006) 3.99
Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet (2011) 3.93
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation (2006) 3.85
Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg (2006) 3.77
Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation (2012) 3.70
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med (2015) 3.69
Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation (2011) 3.63
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med (2005) 3.60
Acute myocardial infarction. Lancet (2003) 3.59
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation (2013) 3.44
Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation (2002) 3.34
Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. Catheter Cardiovasc Interv (2012) 3.32
D-dimer levels and risk of recurrent venous thromboembolism. JAMA (2003) 3.30
Update on myocardial bridging. Circulation (2002) 3.29
Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J (2010) 3.26
Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol (2007) 3.23